The Pool is the total amount of Omega-3’s and Omega-6’s that are in your body. These fatty acids are usually going to be stored in your membranes. In terms of how SmartPrime-Om™ influences the pool; it directly influences the enzymes that are responsible for taking the precursors which are Omega-3 (ALA) and Omega-6 (LA) and it makes it where the enzyme is more malleable, has a higher affinity, and is more drawn to process and take in the Omega-3 vs the Omega-6. In theory this process will increase an individual’s Omega-3 levels and it also makes it less open for the Omega-6 to be able to have a seat in the enzyme.

SmartPrime-Om™ corrects the fatty acid imbalance and it helps to improve the pool of your available Omega-3 fatty acids (EPA, DHA, DPA) that your cells can take to the tissue. SmartPrime-Om™ is essentially creating a biohack to make the enzymes more preferential to Omega-3 metabolism and less to Omega-6 metabolism.

The Package is the form in which fatty acids are received in the body. SmartPrime-Om™ utilizes MSM for a very unique purpose to optimize the packaging of Omega-3’s. MSM makes sure that any Omega-6 (LA) and Omega-3 (ALA) that your body does have is ideally more in the phosphatidylcholine (PC) form (Higher amounts = IDEAL) vs the phosphatidylethanolamine (PE) form (LESS IDEAL).

The issue is that individuals with comorbidities (e.g. Type 2 Diabetes, Obesity, Issues with Methylation) will be stuck in the (PE) form. People with these comorbidities essentially cannot benefit from Omega-3 fatty acids. SmartPrime-Om™ helps individuals with these comorbidities receive the proper packaging of the fatty acids which is the phosphatidylcholine (PC) form.

The Processing is the delivery of the ideal Omega-3 fatty acids (DHA & EPA) in their optimal phospholipid “package” (as PC or 2-acyl-LPC), so they arrive at the organ sites of interest (e.g., brain/retina, immune cells, heart/blood vessels, lungs, liver, fat, muscle, tendon, joints, skin, etc.), and serve as precursors for “processing” those powerful Omega-3 HUFA lipids to generate downstream anti-inflammatory / anti-thrombotic signaling, pro-resolution mediators, and biochemical activity to heal and restore tissue function.

A unique phospholipid that has flown under the radar is lysophosphatidylcholine-linoleic acid (LPC-LA, 18:2). 

This appears to be a uniquely beneficial omega-6 polyunsaturated fatty acid (PUFA), that the body can produce, and correlates with handgrip strength & walking speed in older individuals. 

The Baltimore Longitudinal Study of Aging shows that low blood levels of LPC 18:2 is predictive of metabolic dysfunction and impaired mitochondrial capacity in muscle.

SmartPrime-Om™ may increase the muscle, liver and other tissues’ ability to increase LPC18:2 as yet another beneficial mechanism.